Skip to main content

Table 3 Severity assessment of the ADRs

From: Survivability of hospitalized chronic kidney disease (CKD) patients with moderate to severe estimated glomerular filtration rate (eGFR) after experiencing adverse drug reactions (ADRs) in a public healthcare center: a retrospective 3 year study

Level Description Scale No.* (%)
1 An ADR occurs but requires no change in treatment with the suspected drug. Mild 7 6.8
2 The ADR requires that the suspected drug be withheld, discontinued or otherwise changed. No changed antidote or other treatment is required, and there is no increase in length of stay. Mild 21 20.4
3 The ADR requires that the suspected drug be withheld, discontinued or otherwise changed, and/or an antidote or other treatment is required, and there is no increase in length of stay. Moderate 31 30.1
4 a) Any level 3 ADR that increases length of stay by at least one day, or (b) The ADR is the reason for admission Moderate 30 29.1
5 Any level 4 ADR that requires intensive medical care. Severe 13 12.6
6 The adverse reaction causes permanent harm to the patient. Severe 0 0
7a The adverse reaction indirectly linked to the death of patient. Severe 1 1.0
7b The adverse reaction directly linked to the death of patient. Severe 0 0
  1. Abbreviations: ADR, adverse drug reaction
  2. *The total number of definite or probable ADRs, n = 103